Table of Contents
International Journal of Bacteriology
Volume 2015 (2015), Article ID 671562, 16 pages
http://dx.doi.org/10.1155/2015/671562
Research Article

Inhibition of Quorum Sensing-Controlled Virulence Factors and Biofilm Formation in Pseudomonas aeruginosa by Culture Extract from Novel Bacterial Species of Paenibacillus Using a Rat Model of Chronic Lung Infection

1Department of Microbiology, Faculty of Medicine, MAHSA University, 59100 Kuala Lumpur, Malaysia
2Pantai Hospital Cheras, 56100 Kuala Lumpur, Malaysia
3Institute of Biological Science, Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia
4Department of Medical Microbiology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia

Received 7 October 2014; Accepted 11 December 2014

Academic Editor: Mohammad Mehdi Feizabadi

Copyright © 2015 Saad Musbah Alasil et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Adonizio, K.-F. Kong, and K. Mathee, “Inhibition of quorum sensing-controlled virulence factor production in Pseudomonas aeruginosa by south Florida plant extracts,” Antimicrobial Agents and Chemotherapy, vol. 52, no. 1, pp. 198–203, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. A. Adonizio, Anti-Quorum Sensing Agents from South Florida Medicinal Plants and Their Attenuation of Pseudomonas aeruginosa Pathogenicity, Florida International University, Miami, Fla, USA, 2008.
  3. C. Fuqua and E. P. Greenberg, “Self perception in bacteria: quorum sensing with acylated homoserine lactones,” Current Opinion in Microbiology, vol. 1, no. 2, pp. 183–189, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Hall-Stoodley and P. Stoodley, “Evolving concepts in biofilm infections,” Cellular Microbiology, vol. 11, no. 7, pp. 1034–1043, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. S. Courtois, C. M. Cappellano, M. Ball et al., “Recombinant environmental libraries provide access to microbial diversity for drug discovery from natural products,” Applied and Environmental Microbiology, vol. 69, no. 1, pp. 49–55, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. D. E. Gillespie, S. F. Brady, A. D. Bettermann et al., “Isolation of antibiotics turbomycin A and B from a metagenomic library of soil microbial DNA,” Applied and Environmental Microbiology, vol. 68, no. 9, pp. 4301–4306, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Handelsman, M. R. Rondon, S. F. Brady, J. Clardy, and R. M. Goodman, “Molecular biological access to the chemistry of unknown soil microbes: a new frontier for natural products,” Chemistry & Biology, vol. 5, no. 10, pp. R245–R249, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Bérdy, “Bioactive microbial metabolites: a personal view,” The Journal of Antibiotics, vol. 58, no. 1, pp. 1–26, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. C. Nithya, M. F. Begum, and S. K. Pandian, “Marine bacterial isolates inhibit biofilm formation and disrupt mature biofilms of Pseudomonas aeruginosa PAO1,” Applied Microbiology and Biotechnology, vol. 88, no. 1, pp. 341–358, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. D. Gleim, List of Prokaryotic Name Validity Published, Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen, Braunschweig, Germany, 2014.
  11. Z. He, D. Kisla, L. Zhang, C. Yuan, K. B. Green-Church, and A. E. Yousef, “Isolation and identification of a Paenibacillus polymyxa strain that coproduces a novel lantibiotic and polymyxin,” Applied and Environmental Microbiology, vol. 73, no. 1, pp. 168–178, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. Y. Guo, E. Huang, C. Yuan, L. Zhang, and A. E. Yousef, “Isolation of a Paenibacillus sp. Strain and structural elucidation of its broad-spectrum lipopeptide antibiotic,” Applied and Environmental Microbiology, vol. 78, no. 9, pp. 3156–3165, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. W. Costerton, R. Veeh, M. Shirtliff, M. Pasmore, C. Post, and G. Ehrlich, “The application of biofilm science to the study and control of chronic bacterial infections,” The Journal of Clinical Investigation, vol. 112, no. 10, pp. 1466–1477, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Wu, Z. Song, M. Hentzer et al., “Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice,” Journal of Antimicrobial Chemotherapy, vol. 53, no. 6, pp. 1054–1061, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. T. Coenye and H. J. Nelis, “In vitro and in vivo model systems to study microbial biofilm formation,” Journal of Microbiological Methods, vol. 83, no. 2, pp. 89–105, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. K. P. Rumbaugh and N. L. Carty, “In vivo models of biofilm infection,” in Biofilm Infections, T. Bjarnsholt, P. Ø. Jensen, C. Moser, and N. Høiby, Eds., pp. 267–290, Springer, New York, NY, USA, 2011. View at Publisher · View at Google Scholar
  17. S. Ismail, T. C. Teoh, C. Y. Ung, S. M. Alasil, and R. Omar, “Paenibacillus hemolyticus, the first hemolytic Paenibacillus with growth-promoting activities discovered,” Biologia, vol. 67, no. 6, pp. 1031–1037, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Revdiwala, B. M. Rajdev, and S. Mulla, “Characterization of bacterial etiologic agents of biofilm formation in medical devices in critical care setup,” Critical Care Research and Practice, vol. 2012, Article ID 945805, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Ponnusamy, D. Paul, Y. S. Kim, and J. H. Kweon, “2(5H)-Furanone: a prospective strategy for biofouling-control in membrane biofilm bacteria by quorum sensing inhibition,” Brazilian Journal of Microbiology, vol. 41, no. 1, pp. 227–234, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Yan, Y. Chen, Z. Song et al., “Pathogenic effects of biofilm with chronic Pseudomonas aeruginosa lung infection in rats,” Journal of Nanjing Medical University, vol. 22, no. 1, pp. 34–38, 2008. View at Publisher · View at Google Scholar
  21. S. M. Alasil, R. Omar, S. Ismail, and M. Y. Yusof, “Antibiofilm activity, compound characterization, and acute toxicity of extract from a novel bacterial species of Paenibacillus,” International Journal of Microbiology, vol. 2014, Article ID 649420, 11 pages, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. C. Nithya and S. K. Pandian, “Isolation of heterotrophic bacteria from Palk Bay sediments showing heavy metal tolerance and antibiotic production,” Microbiological Research, vol. 165, no. 7, pp. 578–593, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. K.-F. Kong, S. R. Jayawardena, S. D. Indulkar et al., “Pseudomonas aeruginosa AmpR is a global transcriptional factor that regulates expression of AmpC and PoxB β-lactamases, proteases, quorum sensing, and other virulence factors,” Antimicrobial Agents and Chemotherapy, vol. 49, no. 11, pp. 4567–4575, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. D. E. Ohman, S. J. Cryz, and B. H. Iglewski, “Isolation and characterization of a Pseudomonas aeruginosa PAO mutant that produces altered elastase,” Journal of Bacteriology, vol. 142, no. 3, pp. 836–842, 1980. View at Google Scholar · View at Scopus
  25. C. D. Cox and P. Adams, “Siderophore activity of pyoverdin for Pseudomonas aeruginosa,” Infection and Immunity, vol. 48, no. 1, pp. 130–138, 1985. View at Google Scholar · View at Scopus
  26. P. Jacques, M. Ongena, F. Bernard, R. Fuchs, H. Budzikiewicz, and P. Thonart, “Fluorescent Pseudomonas mainly produce the dihydroform ofy pyoverdine at low specific growth rate,” Letters in Applied Microbiology, vol. 36, no. 5, pp. 259–262, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. G. D. Christensen, W. A. Simpson, J. J. Younger et al., “Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of Staphylococci to medical devices,” Journal of Clinical Microbiology, vol. 22, no. 6, pp. 996–1006, 1985. View at Google Scholar · View at Scopus
  28. S. Limsuwan and S. P. Voravuthikunchai, “Boesenbergia pandurata (Roxb.) Schltr., Eleutherine americana Merr. and Rhodomyrtus tomentosa (Aiton) Hassk. as antibiofilm producing and antiquorum sensing in Streptococcus pyogenes,” FEMS Immunology and Medical Microbiology, vol. 53, no. 3, pp. 429–436, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. J. You, X. Xue, L. Cao et al., “Inhibition of Vibrio biofilm formation by a marine actinomycete strain A66,” Applied Microbiology and Biotechnology, vol. 76, no. 5, pp. 1137–1144, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. L. Baldassarri, R. Creti, S. Recchia et al., “Therapeutic failures of antibiotics used to treat macrolide-susceptible Streptococcus pyogenes infections may be due to biofilm formation,” Journal of Clinical Microbiology, vol. 44, no. 8, pp. 2721–2727, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. I. O. L. A. Resources, Guide for the Care and Use of Laboratory Animals, National Academy Press, Washington, DC, USA, 1996.
  32. M. M. Akhand, M. A. Bari, M. A. Islam, and P. Khondkar, “Sub-acute toxicity study of an antimicrobial metabolite from Streptomyces lalonnensis Sp. Nov., on Long Evan's rats,” Middle-East Journal of Scientific Research, vol. 5, no. 1, pp. 34–38, 2010. View at Google Scholar
  33. N. Hoffmann, T. B. Rasmussen, P. Jensen et al., “Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis,” Infection and Immunity, vol. 73, no. 4, pp. 2504–2514, 2005. View at Google Scholar
  34. H. K. Johansen, F. Espersen, S. S. Pedersen, H. P. Hougen, J. Rygaard, and N. Hoiby, “Chronic Pseudomonas aeruginosa lung infection in normal and athymic rats,” Acta Pathologica, Microbiologica, et Immunologica Scandinavica, vol. 101, no. 3, pp. 207–225, 1993. View at Publisher · View at Google Scholar · View at Scopus
  35. S. S. Pedersen, G. H. Shand, B. L. Hansen, and G. N. Hansen, “Induction of experimental chronic Pseudomonas aeruginosa lung infection with P. aeruginosa entrapped in alginate microspheres,” APMIS, vol. 98, no. 1–6, pp. 203–211, 1990. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Yan, Y. Chen, Z. Song, H. Wu, J. Kong, and X. Qin, “Pathogenic effects of biofilm with chronic Pseudomonas aeruginosa lung infection in rats,” Journal of Nanjing Medical University, vol. 22, no. 1, pp. 34–38, 2008. View at Publisher · View at Google Scholar
  37. H. K. Johansen, H. P. Hougen, S. J. Cryz Jr., J. Rygaard, and N. Hoiby, “Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia in rats,” American Journal of Respiratory and Critical Care Medicine, vol. 152, no. 4, part 1, pp. 1337–1346, 1995. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. Z. Song, A. Kharazmi, H. Wu et al., “Effects of ginseng treatment on neutrophil chemiluminescence and immunoglobulin G subclasses in a rat model of chronic Pseudomonas aeruginosa pneumonia,” Clinical and Diagnostic Laboratory Immunology, vol. 5, no. 6, pp. 882–887, 1998. View at Google Scholar · View at Scopus
  39. H. K. Johansen, F. Espersen, S. J. Cryz Jr. et al., “Immunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection,” Infection and Immunity, vol. 62, no. 8, pp. 3146–3155, 1994. View at Google Scholar · View at Scopus
  40. C. J. Hochstim, J. Y. Choi, D. Lowe, R. Masood, and D. H. Rice, “Biofilm detection with hematoxylin-eosin staining,” Archives of Otolaryngology—Head & Neck Surgery, vol. 136, no. 5, pp. 453–456, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. Y. Wang, E. Cela, S. Gagnon, and N. B. Sweezey, “Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice,” Respiratory Research, vol. 11, article 166, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. R. E. Kania, G. E. M. Lamers, M. J. Vonk et al., “Demonstration of bacterial cells and glycocalyx in biofilms on human tonsils,” Archives of Otolaryngology—Head and Neck Surgery, vol. 133, no. 2, pp. 115–121, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. H. Wu, Z. Song, M. Givskov et al., “Pseudomonas aeruginosa mutations in lasI and rhlI quorum sensing systems result in milder chronic lung infection,” Microbiology, vol. 147, part 5, pp. 1105–1113, 2001. View at Google Scholar
  44. E. Kessler, “β-lytic endopeptidases,” Methods in Enzymology, vol. 248, pp. 740–756, 1995. View at Publisher · View at Google Scholar · View at Scopus
  45. R. A. Bever and B. H. Iglewski, “Molecular characterization and nucleotide sequence of the Pseudomonas aeruginosa elastase structural gene,” Journal of Bacteriology, vol. 170, no. 9, pp. 4309–4314, 1988. View at Google Scholar · View at Scopus
  46. J.-M. Meyer, A. Neely, A. Stintzi, C. Georges, and I. A. Holder, “Pyoverdin is essential for virulence of Pseudomonas aeruginosa,” Infection and Immunity, vol. 64, no. 2, pp. 518–523, 1996. View at Google Scholar · View at Scopus
  47. P. A. Beare, R. J. For, L. W. Martin, and I. L. Lamont, “Siderophore-mediated cell signalling in Pseudomonas aeruginosa: divergent pathways regulate virulence factor production and siderophore receptor synthesis,” Molecular Microbiology, vol. 47, no. 1, pp. 195–207, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. J. B. Lyczak, C. L. Cannon, and G. B. Pier, “Lung infections associated with cystic fibrosis,” Clinical Microbiology Reviews, vol. 15, no. 2, pp. 194–222, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. S. M. Alasil, Antibiofilm activity from novel soil bacterial species of Paenibacillus haemolyticus strain 139SI towards new therapeutic management of chronic and recurrent tonsillitis [Ph.D. thesis], University of Malaya, Kuala Lumpur, Malaysia, 2013.
  50. D. A. Vattem, K. Mihalik, S. H. Crixell, and R. J. C. McLean, “Dietary phytochemicals as quorum sensing inhibitors,” Fitoterapia, vol. 78, no. 4, pp. 302–310, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. N. Huma, P. Shankar, J. Kushwah et al., “Diversity and polymorphism in AHL-Lactonase gene (aiiA) of Bacillus,” Journal of Microbiology and Biotechnology, vol. 21, no. 10, pp. 1001–1011, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. V. C. Kalia, S. C. Raju, and H. J. Purohit, “Genomic analysis reveals versatile organisms for quorum quenching enzymes: acyl-Homoserine lactone-acylase and -lactonase,” The Open Microbiology Journal, vol. 5, pp. 1–13, 2011. View at Google Scholar · View at Scopus
  53. R. Thenmozhi, P. Nithyanand, J. Rathna, and S. K. Pandian, “Antibiofilm activity of coral-associated bacteria against different clinical M serotypes of Streptococcus pyogenes,” FEMS Immunology and Medical Microbiology, vol. 57, no. 3, pp. 284–294, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. K. S. Musthafa, V. Saroja, S. K. Pandian, and A. V. Ravi, “Antipathogenic potential of marine Bacillus sp. SS4 on N-acyl-homoserine- lactone-mediated virulence factors production in Pseudomonas aeruginosa (PAO1),” Journal of Biosciences, vol. 36, no. 1, pp. 55–67, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. D. G. Davies, M. R. Parsek, J. P. Pearson, B. H. Iglewski, J. W. Costerton, and E. P. Greenberg, “The involvement of cell-to-cell signals in the development of a bacterial biofilm,” Science, vol. 280, no. 5361, pp. 295–298, 1998. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Manefield, R. de Nys, N. Kumar et al., “Evidence that halogenated furanones from Delisea pulchra inhibit acylated homoserine lactone (AHL)-mediated gene expression by displacing the AHL signal from its receptor protein,” Microbiology, vol. 145, no. 2, pp. 283–291, 1999. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Hentzer, K. Riedel, T. B. Rasmussen et al., “Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound,” Microbiology, vol. 148, part 1, pp. 87–102, 2002. View at Google Scholar · View at Scopus
  58. T. B. Rasmussen, T. Bjarnsholt, M. E. Skindersoe et al., “Screening for quorum-sensing inhibitors (QSI) by use of a novel genetic system, the QSI selector,” Journal of Bacteriology, vol. 187, no. 5, pp. 1799–1814, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. M. Hentzer, H. Wu, J. B. Andersen et al., “Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors,” The EMBO Journal, vol. 22, no. 15, pp. 3803–3815, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. S. Chusri, K. Sompetch, S. Mukdee et al., “Inhibition of Staphylococcus epidermidis biofilm formation by traditional thai herbal recipes used for wound treatment,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 159797, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Nostro, A. S. Roccaro, G. Bisignano et al., “Effects of oregano, carvacrol and thymol on Staphylococcus aureus and Staphylococcus epidermidis biofilms,” Journal of Medical Microbiology, vol. 56, no. 4, pp. 519–523, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. Y. Wang, T. Wang, J. Hu et al., “Anti-biofilm activity of TanReQing, a traditional Chinese Medicine used for the treatment of acute pneumonia,” Journal of Ethnopharmacology, vol. 134, no. 1, pp. 165–170, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. M. Schuster and E. P. Greenberg, “A network of networks: quorum-sensing gene regulation in Pseudomonas aeruginosa,” International Journal of Medical Microbiology, vol. 296, no. 2-3, pp. 73–81, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. J. P. Pearson, E. C. Pesci, and B. H. Iglewski, “Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes,” Journal of Bacteriology, vol. 179, no. 18, pp. 5756–5767, 1997. View at Google Scholar · View at Scopus
  65. J. M. Brint and D. E. Ohman, “Synthesis of multiple exoproducts in Pseudomonas aeruginosa is under the control of RhlR-RhlI, another set of regulators in strain PAO1 with homology to the autoinducer-responsive LuxR-LuxI family,” Journal of Bacteriology, vol. 177, no. 24, pp. 7155–7163, 1995. View at Google Scholar · View at Scopus
  66. C. van Delden and B. H. Iglewski, “Cell-to-cell signaling and Pseudomonas aeruginosa infections,” Emerging Infectious Diseases, vol. 4, no. 4, pp. 551–560, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. A. M. Albus, E. C. Pesci, L. J. Runyen-Janecky, S. E. H. West, and B. H. Iglewski, “Vfr controls quorum sensing in Pseudomonas aeruginosa,” Journal of Bacteriology, vol. 179, no. 12, pp. 3928–3935, 1997. View at Google Scholar · View at Scopus
  68. C. Reimmann, M. Beyeler, A. Latifi et al., “The global activator GacA of Pseudomonas aeruginosa PAO positively controls the production of the autoinducer N-butyryl-homoserine lactone and the formation of the virulence factors pyocyanin, cyanide, and lipase,” Molecular Microbiology, vol. 24, no. 2, pp. 309–319, 1997. View at Publisher · View at Google Scholar · View at Scopus
  69. R. G. Finch, D. I. Pritchard, B. W. Bycroft, P. Williams, and G. S. A. B. Stewart, “Quorum sensing: a novel target for anti-infective therapy,” Journal of Antimicrobial Chemotherapy, vol. 42, no. 5, pp. 569–571, 1998. View at Publisher · View at Google Scholar · View at Scopus
  70. T. B. May, D. Shinabarger, R. Maharaj et al., “Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients,” Clinical Microbiology Reviews, vol. 4, no. 2, pp. 191–206, 1991. View at Google Scholar · View at Scopus
  71. J. C. Boucher, H. Yu, M. H. Mudd, and V. Deretic, “Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection,” Infection and Immunity, vol. 65, no. 9, pp. 3838–3846, 1997. View at Google Scholar · View at Scopus
  72. L. L. Blackwood and J. E. Pennington, “Influence of mucoid coating on clearance of Pseudomonas aeruginosa from lungs,” Infection and Immunity, vol. 32, no. 2, pp. 443–448, 1981. View at Google Scholar · View at Scopus
  73. C. Morissette, E. Skamene, and F. Gervais, “Endobronchial inflammation following Pseudomonas aeruginosa infection in resistant and susceptible strains of mice,” Infection and Immunity, vol. 63, no. 5, pp. 1718–1724, 1995. View at Google Scholar · View at Scopus
  74. A. Kharazmi, “Interactions of Pseudomonas aeruginosa proteases with the cells of the immune system,” Antibiotics and Chemotherapy, vol. 42, pp. 42–49, 1989. View at Google Scholar · View at Scopus
  75. K. Mathee, O. Ciofu, C. Sternberg et al., “Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung,” Microbiology, vol. 145, no. 6, pp. 1349–1357, 1999. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Linker and R. S. Jones, “A polysaccharide resembling alginic acid from a Pseudomonas micro-organism,” Nature, vol. 204, no. 4954, pp. 187–188, 1964. View at Publisher · View at Google Scholar · View at Scopus
  77. V. Sherbrock-Cox, N. J. Russell, and P. Gacesa, “The purification and chemical characterisation of the alginate present in extracellular material produced by mucoid strains of Pseudomonas aeruginosa,” Carbohydrate Research, vol. 135, no. 1, pp. 147–154, 1984. View at Publisher · View at Google Scholar · View at Scopus
  78. H. A. W. M. Tiddens, “Detecting early structural lung damage in cystic fibrosis,” Pediatric Pulmonology, vol. 34, no. 3, pp. 228–231, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  79. N. Høiby, S. S. Pedersen, E. T. Jensen et al., “Immunology of Pseudomonas aeruginosa infection in cystic fibrosis,” Acta Universitatis Carolinae Medica, vol. 36, no. 1–4, pp. 16–21, 1990. View at Google Scholar · View at Scopus
  80. D. Ren, L. A. Bedzyk, R. W. Ye, S. M. Thomas, and T. K. Wood, “Stationary-phase quorum-sensing signals affect autoinducer-2 and gene expression in Escherichia coli,” Applied and Environmental Microbiology, vol. 70, no. 4, pp. 2038–2043, 2004. View at Publisher · View at Google Scholar · View at Scopus